Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial

Chin Med J (Engl). 2024 Jun 20;137(12):1480-1482. doi: 10.1097/CM9.0000000000003071. Epub 2024 Apr 1.

¹ Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
² Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110055, China.
³ Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350004, China.
⁴ Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
⁵ Department of Dermatology, Peking University First Hospital, Beijing 100034, China.
⁶ Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital), Xi'an, Shaanxi 710006, China.
⁷ Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
⁸ Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
⁹ Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China.
¹⁰ Department of Dermatology, Hospital for Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210042, China.
¹¹ Department of Dermatology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.

No abstract available

Publication types